A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis
Public ClinicalTrials.gov record NCT04603027. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Cohort, Dose-Ranging Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis
Study identification
- NCT ID
- NCT04603027
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Evelo Biosciences, Inc.
- Industry
- Enrollment
- 249 participants
Conditions and interventions
Conditions
Interventions
- EDP1815 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 20, 2020
- Primary completion
- Jul 1, 2021
- Completion
- Dec 5, 2021
- Last update posted
- Dec 18, 2022
2020 – 2021
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Synexus Clinical Research US, Inc. - Santa Rosa | Santa Rosa | California | 95405 | — |
| Synexus Clinical Research US, Inc. - Orlando | Orlando | Florida | 32806 | — |
| Synexus Clinical Research US, Inc. - St. Petersburg | St. Petersburg | Florida | 33781 | — |
| ForCare Clinical Research | Tampa | Florida | 33624 | — |
| Synexus Clinical Research US, Inc. - The Villages | The Villages | Florida | 32162 | — |
| Synexus Clinical Research US, Inc. - Cincinnati | Cincinnati | Ohio | 45236 | — |
| Oregon Medical Research Center PC | Portland | Oregon | 97223 | — |
| Synexus Clinical Research US, Inc. - Anderson | Anderson | South Carolina | 29621 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04603027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04603027 live on ClinicalTrials.gov.